Search - tctmd.com

Displaying 21 - 40 of 142

Sort: Relevancy | Date

News Daily News

CMS Finalizes Rule Allowing Reimbursement of PCI in Ambulatory Centers

Todd Neale

November 04, 2019

News Daily News

DAPT Cuts Saphenous Vein Graft Failure After CABG: Meta-analysis

Michael O'Riordan

October 17, 2019

News Daily News

FDA Gives Rivaroxaban Another VTE-Related Indication

Todd Neale

October 14, 2019

News Daily News

Study Unearths Gender Disparities in Twitter Influence

Yael L. Maxwell

October 14, 2019

News TCT 2019

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

Shelley Wood

September 26, 2019

News Conference News TCT 2019

AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups

Todd Neale

September 26, 2019

https://www.tctmd.com/news/ideal-lm-probes-short-dapt-and-bioabsorbable-polymer-stent-left-main-disease

News Conference News TCT 2019

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

Michael O'Riordan

September 26, 2019

Presentation TCT 2019

IDEAL-LM: A Randomized Trial of a Bioabsorbable Polymer DES With 4-Month DAPT vs. a Durable Polymer DES With 12-Month DAPT in Patients With Left Main Coronary Artery Disease

Presenter: Robert-Jan Van Geuns

September 26, 2019

News Conference News TCT 2019

From Ceiling Suspension to Eye-Tracking: Innovation Continues for Cath Lab Radiation Protection

Yael L. Maxwell

September 25, 2019

Presentation TCT 2019

TCT 117: Novel optical coherence tomography classification of intravascular lesions in patients with chronic thromboembolic pulmonary hypertension treated with balloon pulmonary angioplasty.

Presenter: Stanislaw Jankiewicz

September 25, 2019

Presentation TCT 2019

Case 8 (From India): Expanding Indications of TAVR in India

Presenter: RAMA KRISHNA JANAPATI

September 25, 2019

Presentation TCT 2019

TCT 48: Bioresorbable Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis (COMPARE-ABSORB trial) : Very late device thrombosis while on extended DAPT

Presenter: Robert-Jan Van Geuns

September 25, 2019

$TCT 33: Bioprosthetic valve fracture performed pre versus post valve-in-valve transcatheter aortic valve replacement: Insights from bench testing$

Presentation TCT 2019

TCT 33: Bioprosthetic valve fracture performed pre versus post valve-in-valve transcatheter aortic valve replacement: Insights from bench testing

Presenter: Janarthanan Sathananthan, MD

September 25, 2019

Presentation TCT 2019

Novel Access Routes for Structural Heart Intervention: Transcarotid, Transcaval, Transaxillary, Etc.

Presenter: Janet Wyman

September 25, 2019

News Daily News

Bleeding on Low-Dose Antithrombotic Therapy a ‘Red Flag’ for New Cancers

Yael L. Maxwell

September 20, 2019

News Daily News

Major Bleeding Mostly Early, Not Severe With Rivaroxaban Plus Aspirin in COMPASS

Caitlin E. Cox

September 20, 2019

News Conference News HFSA 2019

New PROVE-HF Data May Reassure Clinicians of Sacubitril/Valsartan Benefit in HFrEF

L.A. McKeown

September 18, 2019

News Conference News ESC 2019

Reduced-Dose Rivaroxaban May Be an Option After LAA Occlusion, ADRIFT Hints

Todd Neale

September 11, 2019

News Conference News ESC 2019

LAA Occluders, NOACs Provide Similar Outcomes in High-risk A-fib Patients: PRAGUE-17

Todd Neale

September 10, 2019

News Conference News ESC 2019

TRANSIENT: Treatment Timing Inconsequential When STEMI Resolves Before Revascularization

L.A. McKeown

September 09, 2019

Advertisement

CMS Finalizes Rule Allowing Reimbursement of PCI in Ambulatory Centers

DAPT Cuts Saphenous Vein Graft Failure After CABG: Meta-analysis

FDA Gives Rivaroxaban Another VTE-Related Indication

Study Unearths Gender Disparities in Twitter Influence

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

IDEAL-LM: A Randomized Trial of a Bioabsorbable Polymer DES With 4-Month DAPT vs. a Durable Polymer DES With 12-Month DAPT in Patients With Left Main Coronary Artery Disease

From Ceiling Suspension to Eye-Tracking: Innovation Continues for Cath Lab Radiation Protection

TCT 117: Novel optical coherence tomography classification of intravascular lesions in patients with chronic thromboembolic pulmonary hypertension treated with balloon pulmonary angioplasty.

Case 8 (From India): Expanding Indications of TAVR in India

TCT 48: Bioresorbable Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis (COMPARE-ABSORB trial) : Very late device thrombosis while on extended DAPT

TCT 33: Bioprosthetic valve fracture performed pre versus post valve-in-valve transcatheter aortic valve replacement: Insights from bench testing

Novel Access Routes for Structural Heart Intervention: Transcarotid, Transcaval, Transaxillary, Etc.

Bleeding on Low-Dose Antithrombotic Therapy a ‘Red Flag’ for New Cancers

Major Bleeding Mostly Early, Not Severe With Rivaroxaban Plus Aspirin in COMPASS

New PROVE-HF Data May Reassure Clinicians of Sacubitril/Valsartan Benefit in HFrEF

Reduced-Dose Rivaroxaban May Be an Option After LAA Occlusion, ADRIFT Hints

LAA Occluders, NOACs Provide Similar Outcomes in High-risk A-fib Patients: PRAGUE-17

TRANSIENT: Treatment Timing Inconsequential When STEMI Resolves Before Revascularization

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content